Efficacy, Durability and Safety of Faricimab for Patients with Neovascular Age-Related Macular Degeneration: 48-Week Results from the Phase 3 LUCERNE China Subpopulation
Asia-Pacific journal of ophthalmology (Philadelphia, Pa)（2025）
Key words
angiopoietin-2,China,faricimab,neovascular age-related macular degeneration,vascular endothelial growth factor-A
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined